<DOC>
	<DOCNO>NCT02840747</DOCNO>
	<brief_summary>This document protocol non-interventional human research study investigator hop good understand change take place T cell Cutaneous T-cell lymphoma ( CTCL ) . The purpose study establish protocol collection storage tissue sample patient CTCL future research study . Collection storage tissue sample control patient also carry .</brief_summary>
	<brief_title>Tissue Repository : CTCL Collection Protocol</brief_title>
	<detailed_description>CTCL heterogeneous group non-Hodgkin 's lymphoma characterize chronic inflammation accumulation malignant T cell skin . In order carry research expand knowledge develop effective treatment , tissue sample CTCL patient presume known disorder require tissue sample control patient require compare difference affect healthy population . Scientists able test new idea new technology apparent available present moment tissue repository future . This type information thus great advantage future patient disease .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Lymphomatoid Papulosis</mesh_term>
	<criteria>Patients CTCL Lymphomatoid Papulosis ( LYP ) : clinical histologic diagnosis ) newly diagnose , b ) progressive , c ) relapse CTCL LYP initiate change therapy . Patients Sézary Syndrome ( SS ) stage IV B CTCL define blood involvement flow cytometry morphology : ( 1 ) ≥1000/μL Sézary cell morphology ; ( 2 ) Cluster differentiation 4 ( CD4 ) /cluster differentiation 8 ( CD8 ) ratio ≥10 ; ( 3 ) CD4+cluster differentiation 7 ( CD7 ) cell ≥40 percent ; ( 4 ) CD4+cluster differentiation 26 ( CD26 ) cell ≥30 percent . Ability understand willing sign willing informed consent document . Age ≥ 18 year . Inclusion Criteria Age Sex Matched Controls : Matched sex , age +/ 10 year . Ability sign inform consent document . Patients without benign inflammatory skin condition include , limited , eczema , psoriasis , dermatitis Patients without skin condition require treatment systemic immunosuppressive , biologic , chemotherapeutic agent . Patients history previous lymphoma CTCL SS LYP . Medical illnesses potential suppressive activate impact immune bowel function judge investigator . Current , viable pregnancy . Anemia document hemoglobin laboratory value &lt; 7.5 g/dl within past 6 month . Exclusion Criteria Age Sex Matched Controls : Previous history CTCL , SS , LYP , lymphoma . Previous history Human Immunodeficiency Virus ( HIV ) infection . Anemia document hemoglobin laboratory value &lt; 7.5 g/dl within past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Lymphomatoid Papulosis</keyword>
	<keyword>Sézary Syndrome</keyword>
	<keyword>T-Cell Lymphoma</keyword>
</DOC>